Patents by Inventor Giampiero Ventimiglia

Giampiero Ventimiglia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Eluxadoline crystalline forms and processes for their preparation
    Patent number: 10738013
    Abstract: Novel crystalline forms of Eluxadoline, having the formula (I), are described. Also described are the processes for the preparation of said crystalline forms.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: August 11, 2020
    Assignee: Quimica Sintetica, S.A.
    Inventors: Giuseppe Barreca, Giampiero Ventimiglia, Norberto Masciocchi
  • AMORPHOUS POWDER COMPRISING AN ANGIOTENSIN RECEPTOR BLOCKER AND A NEUTRAL ENDOPEPTIDASE INHIBITOR
    Publication number: 20200179290
    Abstract: Several methods for the preparation of an amorphous powder that includes a 1:1 stoichiometric mixture of the trisodium salts of Valsartan and Sacubitril are described, as well as the resulting amorphous powder, pharmaceutical compositions containing it, and their use in the treatment of essential hypertension and/or cardiac failure.
    Type: Application
    Filed: February 7, 2020
    Publication date: June 11, 2020
    Applicant: Quimica Sintetica, S.A.
    Inventors: Giuseppe Barreca, Giampiero Ventimiglia, Sonja Bellomi
  • ELUXADOLINE CRYSTALLINE FORMS AND PROCESSES FOR THEIR PREPARATION
    Publication number: 20190345114
    Abstract: Novel crystalline forms of Eluxadoline, having the formula (I), are described. Also described are the processes for the preparation of said crystalline forms.
    Type: Application
    Filed: January 26, 2018
    Publication date: November 14, 2019
    Applicant: Quimica Sintetica, S.A.
    Inventors: Giuseppe Barreca, Giampiero Ventimiglia, Norberto Masciocchi
  • AMORPHOUS POWDER COMPRISING AN ANGIOTENSIN RECEPTOR BLOCKER AND A NEUTRAL ENDOPEPTIDASE INHIBITOR
    Publication number: 20180353430
    Abstract: Several methods for the preparation of an amorphous powder comprising a 1:1 stoichiometric mixture of the trisodium salts of Valsartan and Sacubitril are described, as well as the resulting amorphous powder, pharmaceutical compositions containing it, and their use in the treatment of essential hypertension and/or cardiac failure.
    Type: Application
    Filed: July 12, 2016
    Publication date: December 13, 2018
    Applicant: Quimica Sintetica, S.A.
    Inventors: Giuseppe Barreca, Giampiero Ventimiglia, Sonja Bellomi